Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04721015
Title Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | FRA | ESP | AUS

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute /ID# 231209 Boston Massachusetts 02215 United States Details
Washington University-School of Medicine /ID# 225698 Saint Louis Missouri 63110 United States Details
Carolina BioOncology Institute /ID# 225358 Huntersville North Carolina 28078 United States Details
Lifespan Cancer Institute at Rhode Island Hospital /ID# 226145 Providence Rhode Island 02903-4923 United States Details
South Texas Accelerated Research Therapeutics /ID# 225359 San Antonio Texas 78229 United States Details
Virginia Cancer Specialists - Fairfax /ID# 225693 Fairfax Virginia 22031 United States Details
Wollongong Hospital /ID# 228350 Wollongong New South Wales 2500 Australia Details
Austin Health /ID# 225638 Heidelberg Victoria 3084 Australia Details
AP-HM - Hopital de la Timone /ID# 225779 Marseille CEDEX 05 Bouches-du-Rhone 13385 France Details
Institut Bergonie /ID# 225778 Bordeaux Gironde 33000 France Details
Institut Curie /ID# 225829 Paris CEDEX 05 Paris 75248 France Details
Centre Georges François Leclerc /ID# 226760 Dijon 21079 France Details
Institut Claudius Regaud /ID# 225780 Toulouse 31052 France Details
Rambam Health Care Campus /ID# 225586 Haifa H_efa 3109601 Israel Details
The Chaim Sheba Medical Center /ID# 225585 Ramat Gan Tel-Aviv 5265601 Israel Details
NHO Nagoya Medical Center /ID# 244412 Nagoya-shi Aichi 460-0001 Japan Details
National Cancer Center Hospital East /ID# 225725 Kashiwa-shi Chiba 277-8577 Japan Details
National Hospital Organization Shikoku Cancer Center /ID# 240821 Matsuyama-shi Ehime 791-0280 Japan Details
National Hospital Organization Kyushu Cancer Center /ID# 240761 Fukuoka-shi Fukuoka 811-1395 Japan Details
National Cancer Center Hospital /ID# 225724 Chuo-ku Tokyo 104-0045 Japan Details
National Cancer Center /ID# 231887 Goyang-si Gyeonggido 10408 Korea, Republic of Details
Asan Medical Center /ID# 231886 Seoul Seoul Teugbyeolsi 05505 Korea, Republic of Details
Samsung Medical Center /ID# 231888 Seoul Seoul Teugbyeolsi 06351 Korea, Republic of Details
Yonsei University Health System Severance Hospital /ID# 233774 Seoul 03722 Korea, Republic of Details
Hospital Universitario Puerta de Hierro - Majadahonda /ID# 226096 Majadahonda Madrid 28222 Spain Details
Hospital Universitario Vall d'Hebron /ID# 225976 Barcelona 08035 Spain Details
Hospital Universitario Fundacion Jimenez Diaz /ID# 225975 Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre /ID# 225977 Madrid 28041 Spain Details
Hospital Universitario Virgen de la Victoria /ID# 225978 Malaga 29010 Spain Details
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 243345 Kaohsiung Keelung 807 Taiwan Details
National Cheng Kung University Hospital /ID# 225944 Tainan Keelung 704 Taiwan Details
National Taiwan University Hospital - Hsinchu branch /ID# 243610 Hsinchu City 30059 Taiwan Details
Linkou Chang Gung Memorial Hospital /ID# 225946 Taoyuan City 333 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field